A Cross-sectional Study of Group B Streptococcus–Associated Sepsis, Coinfections, and Antibiotic Susceptibility Profile in Neonates in Pakistan. (August 2020)
- Record Type:
- Journal Article
- Title:
- A Cross-sectional Study of Group B Streptococcus–Associated Sepsis, Coinfections, and Antibiotic Susceptibility Profile in Neonates in Pakistan. (August 2020)
- Main Title:
- A Cross-sectional Study of Group B Streptococcus–Associated Sepsis, Coinfections, and Antibiotic Susceptibility Profile in Neonates in Pakistan
- Authors:
- Asghar, Samra
Khan, Junaid Ali
Mahmood, Muhammad Shahid
Arshad, Muhammad Imran - Other Names:
- Dowling Donna section editor.
Schierholz Elizabeth section editor. - Abstract:
- Abstract : Background: Neonatal sepsis is a leading cause of morbidity and early-life mortality worldwide, and previous data have reported the highest neonatal mortality rate in Pakistan. Purpose: The present study aimed to decipher the prevalence of group B Streptococcus (GBS)–associated sepsis, coinfections, and antibiotic susceptibility of isolated microbes in neonates. Methods: Blood samples of 100 cases of neonatal sepsis were subcultured on blood agar, GBS agar, and MacConkey agar for isolation of GBS and suspected microbes. Results: Of 100 neonatal blood samples, 85 blood samples were culture-positive, including mixed culture growth (n = 18), 25 samples as early-onset neonatal sepsis (EONS) and 60 as late-onset neonatal sepsis (LONS). Staphylococcus aureus showed high percent positivity (31.4%), followed by Candida sp (16.5%), GBS (14.1%), Klebsiella (14.1%), Staphylococcus epidermidis (11.8%), Pseudomonas (9.4%), Acinetobacter (9.4%), Esherichia coli (8.2%), and Enterococcus (5.9%). GBS was isolated more frequently from EONS than from LONS with 50% coinfections. Mode of delivery, gender, and respiratory distress in neonates were significantly associated with culture-positive sepsis. GBS isolates were highly (91.7%) susceptible to vancomycin, cefotaxime, and chloramphenicol, followed by penicillin (83.3%), ampicillin, and tetracycline (75%). GBS isolates were resistant to erythromycin, clindamycin, ciprofloxacin, and linezolid. Implications for Practice: Our findingsAbstract : Background: Neonatal sepsis is a leading cause of morbidity and early-life mortality worldwide, and previous data have reported the highest neonatal mortality rate in Pakistan. Purpose: The present study aimed to decipher the prevalence of group B Streptococcus (GBS)–associated sepsis, coinfections, and antibiotic susceptibility of isolated microbes in neonates. Methods: Blood samples of 100 cases of neonatal sepsis were subcultured on blood agar, GBS agar, and MacConkey agar for isolation of GBS and suspected microbes. Results: Of 100 neonatal blood samples, 85 blood samples were culture-positive, including mixed culture growth (n = 18), 25 samples as early-onset neonatal sepsis (EONS) and 60 as late-onset neonatal sepsis (LONS). Staphylococcus aureus showed high percent positivity (31.4%), followed by Candida sp (16.5%), GBS (14.1%), Klebsiella (14.1%), Staphylococcus epidermidis (11.8%), Pseudomonas (9.4%), Acinetobacter (9.4%), Esherichia coli (8.2%), and Enterococcus (5.9%). GBS was isolated more frequently from EONS than from LONS with 50% coinfections. Mode of delivery, gender, and respiratory distress in neonates were significantly associated with culture-positive sepsis. GBS isolates were highly (91.7%) susceptible to vancomycin, cefotaxime, and chloramphenicol, followed by penicillin (83.3%), ampicillin, and tetracycline (75%). GBS isolates were resistant to erythromycin, clindamycin, ciprofloxacin, and linezolid. Implications for Practice: Our findings evidenced GBS-associated risk factors and antibiotic susceptibility pattern of neonatal sepsis, which will help clinicians in management, control, and treatment of neonatal sepsis. Implications for Research: The epidemiological evidence of GBS-associated neonatal sepsis, demographic characteristics, risk factor data analysis, and drug resistance pattern has disease prevention implications in neonates in low-income countries including Pakistan. … (more)
- Is Part Of:
- Advances in neonatal care. Volume 20:Number 4(2020)
- Journal:
- Advances in neonatal care
- Issue:
- Volume 20:Number 4(2020)
- Issue Display:
- Volume 20, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 20
- Issue:
- 4
- Issue Sort Value:
- 2020-0020-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-08
- Subjects:
- drug resistance -- GBS -- neonates -- risk factors -- sepsis
Newborn infants -- Medical care -- Periodicals
Newborn infants -- Diseases -- Nursing -- Periodicals
Premature infants -- Hospital care -- Periodicals
618.9201 - Journal URLs:
- http://www.advancesinneonatalcare.org ↗
http://www.sciencedirect.com/science/journal/15360903 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/ANC.0000000000000701 ↗
- Languages:
- English
- ISSNs:
- 1536-0903
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0709.463000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19145.xml